Compendium of Inflammatory Diseases.
| Autor Corporativo: | |
|---|---|
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Basel :
Springer Basel : Imprint: Springer,
2016.
|
| Edición: | 1st ed. 2016. |
| Materias: |
Tabla de Contenidos:
- Adhesion molecules of neutrophils
- Anaphylaxis (Immediate hypersensitivity): from old to new mechanisms
- Antiviral Responses
- Autophagy and Inflammation
- Basophils
- Cell signalling in neutrophils
- Co-stimulatory Receptors
- Dendritic Cells
- GILZ-Related Regulation of Inflammation
- Glial Cells
- Immunoglobulin receptors and inflammation.-Inflammation and autoimmunity
- Inflammatory Bowel Disease Models in Animals
- Leukocyte Recruitment
- Lymphocyte homing and trafficking
- Macrophage heterogeneity during inflammation
- Mast Cells
- Mechanisms of Macrophage Migration in 3-Dimensional Environments
- Microvascular Responses to Inflammation
- Modulation of inflammation by key nutrials
- Natural Killer Cells
- Neutrophil Extracellular Traps
- Neutrophil oxidative burst
- Obesity and Inflammation
- Osteoclasts in Inflammation
- Parasitism: A Unique Lifestyle Reflecting Dynamic Parasite- and Host(s)-Co-driven Processes
- Platelet, Endothelium, and Inflammation
- Regulatory T cells
- Sepsis Models in Animals
- Skin inflammation models in animals
- Th17 Response
- Toll-Like Receptors
- Angiogenesis Inhibitors
- Anti-asthma Drugs, Overview
- Anti-histamines
- Anti-muscarinics
- Antibiotics as anti-inflammatory drugs
- Antimalarial Drugs
- Azathioprine/Thiopurines
- Beta2 Agonists
- CD 20 Inhibitors – Rituximab
- CD80/86 Inhibitors
- Chromones – Cromoglycate and Nedocromil
- Colony stimulating factor therapeutics
- Corticosteroids
- Coxibs
- Disease-Modifying Anti-Rheumatic Drugs
- Fenamates
- Flavonoids as anti-inflammatory agents
- Gold Complexes
- Interleukin 1 Inhibitors
- Interleukin 12/23 Inhibitors: Ustekinumab Interleukin-6 Inhibitor – Tocilizumab
- Leflunomide
- Medicinal Fatty Acids
- Methotrexate.-NO-donating anti-inflammatory drugs
- Non-steroidal anti-inflammatory drugs
- Phosphodiesterase-4 inhibitors
- Propionic Acid Derivative Drugs (Profens)
- Salicylates
- Sulfasalazine and Related Drugs
- Tetracyclines
- Theophylline
- TNF Inhibitors
- Acute exacerbations of airway inflammation
- Allergic Disorders
- Alzheimer's Disease
- Antiphospholipid antibody syndrome
- Asthma
- Atopic dermatitis
- Autoinflammatory syndromes
- Behcet’s disease
- Bronchiolitis obliterans
- Cancer and inflammation
- Cogan’s syndrome
- COPD
- Diabetes type I
- Diabetes type II
- Diffuse panbronchiolitis
- Gaucher's disease
- Genetic susceptibility to inflammatory diseases
- Gout
- Graft vs Host Disease
- Granulomatosis with Polyangiitis (GPA)
- Grave’s disease.-Guillaine-Barre disease
- Henoch-Schönlein Purpura
- Idiopathic Thrombocytopenic Purpura
- Inflammatory bowel disease
- Juvenile idiopathic arthritis
- Kawasaki Disease
- Lyme disease
- Osteoarthritis.-Osteoarthritis Genetics
- Polymyositis and Dermatomyositis
- Rheumatic Fever
- Rheumatoid arthritis
- Role of Cell Therapy in Autoimmune Disease
- Sarcoidosis
- Sepsis
- Spondylarthropathies
- ACKR3
- Adhesion molecules
- Alarmins
- Antibacterial Host .-Defense Peptides
- Bacterial Lipopolysaccharide.-Biofilm
- Bone Morphogenetic Proteins in Inflammation
- C5a Receptors
- CCL18
- CCR1
- Ceramide 1-Phosphate: A Mediator of Inflammatory Responses
- Complement System
- CXCL4 und CXCL4L1
- CXCR1 and CXCR2 and Ligands
- CXCR3 and its Ligands
- Cytokines
- Cytolytic Granules
- Foxp3
- Heat Shock Proteins
- Histamine
- IFNgamma
- IkappaB
- Inflammasomes
- Interleukin 1
- Interleukin 10
- Interleukin 12
- Interleukin 17
- Interleukin 18
- Interleukin 18 Binding Protein
- Interleukin 2
- Interleukin 22
- Interleukin 23
- Interleukin 27
- Interleukin 32
- Interleukin 36 Cytokines
- Interleukin 4 and the related cytokines (Interleukin 5 and Interleukin 13)
- Interleukin 6
- Interleukin 9
- Interleukin-33
- Janus Kinases (JAKs)/STAT Pathway
- Kinins
- Leukotrienes
- Mammalian Target of Rapamycin (mTOR)
- MAP Kinase Pathways
- NFkappaB
- Nitric oxide
- Nuclear Receptor Signaling in the Control of Inflammation
- Pathogen-Associated Molecular Patterns (PAMPs)
- Pentraxins
- Prostanoids
- Protease-Activated Receptors
- Reactive oxygen species
- Substance P in Inflammation
- TGF-b superfamily cytokine MIC-1/GDF15 in health and inflammatory diseases
- TNFalpha
- Type I Interferons.